As of 2026-04-06, the Intrinsic Value of Metropolis Healthcare Ltd (METROPOLIS.NS) is 132.89 INR. This METROPOLIS.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 421.75 INR, the upside of Metropolis Healthcare Ltd is -68.50%.
The range of the Intrinsic Value is 105.68 - 180.99 INR
Based on its market price of 421.75 INR and our intrinsic valuation, Metropolis Healthcare Ltd (METROPOLIS.NS) is overvalued by 68.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 105.68 - 180.99 | 132.89 | -68.5% |
| DCF (Growth 10y) | 135.93 - 221.99 | 167.29 | -60.3% |
| DCF (EBITDA 5y) | 187.59 - 288.11 | 224.66 | -46.7% |
| DCF (EBITDA 10y) | 204.95 - 320.07 | 248.00 | -41.2% |
| Fair Value | 47.42 - 47.42 | 47.42 | -88.76% |
| P/E | 290.40 - 367.38 | 333.05 | -21.0% |
| EV/EBITDA | 150.00 - 337.03 | 229.66 | -45.5% |
| EPV | 88.56 - 108.30 | 98.43 | -76.7% |
| DDM - Stable | 56.75 - 128.32 | 92.54 | -78.1% |
| DDM - Multi | 83.55 - 146.21 | 106.28 | -74.8% |
| Market Cap (mil) | 90,861.40 |
| Beta | 0.25 |
| Outstanding shares (mil) | 215.44 |
| Enterprise Value (mil) | 92,268.81 |
| Market risk premium | 8.31% |
| Cost of Equity | 11.56% |
| Cost of Debt | 8.91% |
| WACC | 11.45% |